Loading clinical trials...

Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma | Clinical Trials | Clareo Health

TERMINATEDPHASE2

Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma

Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma: Chest Radiograph Versus Chest CT

NCT01612481•Centre Oscar Lambret

View on ClinicalTrials.gov

Summary

Cancer surveillance has a significant cost and generate anxiety for the patient. It is important to avoid exams that will not modify health support or whose results wont allow to decide.

Detailed Description

Cancer surveillance has a significant cost and generate anxiety for the patient. It is important to avoid exams that will not modify health support or whose results wont allow to decide. Our study will help rationalise surveillance of soft tissue sarcoma and standardize medical practices.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•soft tissue sarcoma, histologically proven
•tumor size \> 5 cm (SBR grade 2) or whatever size (SBR grade 3)
•complete excision (R0 or R1)
•no metastasis (checked by spiral chest CT)
•social security covered
•informed signed consent

Exclusion Criteria

•bone, visceral, uterine, retroperitoneal sarcoma
•GIST
•other malignant tumor
•patients over 70, or for whom thoracic surgery is excluded
•pneumoconiosis or known system disease
•breast feeding or pregnant woman
•patient unable to undergo trail medical follow up for geographic, social or psychological reasons

Locations (3)

Centre Georges François Leclerc

Dijon, France

Oscar Lambret Center

Lille, France

Léon BERARD Center

Lyon, France

Key Dates

Start Date

April 2, 2012

Primary Completion Date

October 1, 2015

Completion Date

May 19, 2016

Last Updated

March 16, 2026

Enrollment

ACTUAL participants

Conditions

Soft Tissue SarcomaLung Metastasis

Interventions

chest radiography

PROCEDURE

chest CT

PROCEDURE

Actinium Therapy for Late-stage Aggressive Sarcomas

NCT07156565

Advanced Soft Tissue Sarcoma

View study

RECRUITINGNA

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

NCT02701153

Recurrent Adult Soft Tissue Sarcoma

View study

RECRUITING

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

NCT07432932

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 16, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma

Inclusion Criteria

Exclusion Criteria

Actinium Therapy for Late-stage Aggressive Sarcomas

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma